Company intelligence / Profile preview
Cell Tech Pharmed
Karaj, Alborz, Iran
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Cell Tech Pharmed is a leading Iranian biotechnology company specializing in the development and industrial-scale manufacturing of stem cell and regenerative medicine products. Established in 2014 as a strategic collaboration between the Barakat Pharmaceutical Group and the Royan Institute, the company operates a state-of-the-art GMP-certified facility dedicated to advanced therapy medicinal products (ATMPs). Its portfolio includes ReColorCell, the first cell-based product registered in the Iranian Drug List for the treatment of vitiligo, as well as therapies for osteoarthritis and skin rejuvenation. The company leverages autologous and allogeneic cell technologies to address unmet medical needs in orthopedics, dermatology, and cardiology. Cell Tech Pharmed is recognized as a pioneer in the Middle East for its large-scale cell therapy production capabilities.
- Therapeutic areas
- ImmunologyCardiovascularNeurologyDermatologyInfectious DiseasesRheumatology
- Modalities
- Stem cell therapyCell therapyAutologous cell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Royan InstituteBarakat Pharmaceutical Group
Beyond the preview
Go deeper on Cell Tech Pharmed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cell Tech Pharmed.